Screening for aetiology of thrombophilia: A high prevalence of protein S abnormality

Annals of Clinical Biochemistry

Volumn 36, Issue 4, 1999, Pages 423-432

  Tsuda, H ^a   Hattori, S ^a   Tanabe, S ^a   Iida, H ^a   Nakahara, M ^a   Nishioka, S ^a   Fujise, M ^a   Kinoshita, S ^a   Okubo, K ^a   Hamasaki, Naotaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; LUPUS ANTICOAGULANT; PLASMINOGEN; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HUMAN; JAPAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; PRIORITY JOURNAL; THROMBOPHILIA; ULCERATIVE COLITIS;

EID: 0032808934     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329903600404     Document Type: Article

References (36)

1. 1 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-30
2. 2 Hirsh J, Prins MH, Samama M. Approach to the thrombophilic patient for hemostasis and thrombosis: basic principles and clinical practice. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn. Philadelphia: JB Lippincott, 1994: 1543-61
3. 3 Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part I. Thromb Haemost 1996; 76: 651-62
4. 4 Rosenberg RD, Rosenberg JS. Natural anticoagulant mechanisms. J Clin Invest 1984; 74: 1-6
5. 5 Rodgers GM, Greenberg CS, Shuman MA. Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood 1983; 61: 1155-62
6. 6 Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-6
7. 7 Pabinger I, Brücker S, Kyrle PA, Schneider B, Korninger HC, Niessner H, et al. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Croag Fibrinolysis 1992; 3: 547-83
8. 8 Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6
9. 9 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22
10. 10 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4
11. 11 Takamiya O, Ishida F, Kodaira H, Kitano K. APC-resistanee and Mnl 1 genotype (Gln 506) of coagulation factor V are rare in Japanese population. Thromb Haemost 1995; 74: 996
12. 12 Feinstein D. Lupus anticoagulants, anticardiolipin antibodies, fetal loss, and systemic lupus erythematosus. Blood 1992; 80: 859-62
13. 13 Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' autoantibodies. Blood 1994; 84: 2854-67
14. 14 Sakuragawa N, Takahashi K, Kondo S, Koide T. Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis. Thrombos Res 1983; 31: 305-17
15. 15 Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986; 67: 504-8
16. 16 Colaco CB, Elkon KB. The lupus anticoagulant: a disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum 1985; 28: 67-74
17. 17 Dahlbäck B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 1983; 209: 837-46
18. 18 Schmidel DK, Tatro AV, Phelps LG, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry 1990; 29: 7845-52
19. 19 Ploos van Amstel HK, Reitsma PH, van der Logt PE, Bertina RM. Intron-exon organization of the active human protein S gene PSα and its pseudogene PSβ: duplication and silencing during primate evolution. Biochemistry 1990; 29: 7853-61
20. 20 Edenbrandt C-M, Lundwall A, Wydro R, Stenflo J. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 1990; 29: 7861-8
21. 21 Olds RJ, Lane DA, Chowdhury V, de Stefano V, Leone G, Thein SL. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32: 4216-24
22. 22 Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci USA 1986; 83: 546-50
23. 23 Petersen TE, Martzen MR, Ichinose A, Davie EW. Characterization of the gene for human plasminogen, a key proenzyme in the fribrinolytic system. J Biol Chem 1990; 265: 6104-11
24. 24 Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-91
25. 25 Ploos van Amstel HK, van der Zanden AL, Bakker E, Reitsma PH, Bertina RM. Two genes homologous with human protein S cDNA are located on chromosome 3. Thromb Haemost 1987; 58: 982-7
26. 26 Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reactions. Genomics 1989; 5: 874-9
27. 27 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7
28. 28 Gandrille S, Borgel D, Ireland H, Lane DA, Simmonds R, Reitsma PH, et al. Protein S deficiency: a database of mutations. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost 1997; 77: 1201-14
29. 29 Kauffmann RH, de Graeff J, de la Rivière GB, van Es LA. Unilateral renal vein thrombosis and nephrotic syndrome: report of a case with protein selectivity and antithrombin III clearance studies. Am J Med 1976; 60: 1048-54
30. 30 Kauffmann RH, Veltkamp JJ, van Tilburg NH, van Es LA. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 1978; 65: 607-13
31. 31 Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, et al. Antithrombin III mutation database: first update. Thromb Haemost 1993; 70: 361-9
32. 32 Kudo T. Spontaneous occlusion of the circle of Willis: a disease apparently confined to Japanese. Neurology 1968; 18: 485-96
33. 33 Aoki N, Tateno K, Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: new methods for the detection of plasminogen variants. Biochem Genet 1984; 22: 871-81
34. 34 Ichinose A, Espling ES, Takamatsu J, Saito H, Shinmyozu K, Maruyama I, et al. Two types of abnormal genes for plasminogen in families with a predisposition for thrombosis. Proc Natl Acad Sci USA 1991; 88: 115-9
35. 35 Tsutsumi S, Saito T, Sakata T, Miyata I, Ichinose A. Genetic diagnosis of dysplasminogenemia: detection of an Ala601-Thr mutation in 118 out of 125 families and identification of a new Asp676-Asn mutation. Thromb Haemost 1996; 76: 135-8
36. 36 Parke AL, Weinstein RE, Bona RD, Maier DB, Walker FJ. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S. Am J Med 1992; 93: 49-56